Form 8-K - Current report:
SEC Accession No. 0001193125-25-009911
Filing Date
2025-01-22
Accepted
2025-01-22 06:04:50
Documents
20
Period of Report
2025-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d849453d8k.htm   iXBRL 8-K 32752
2 EX-10.1 d849453dex101.htm EX-10.1 27222
3 EX-99.1 d849453dex991.htm EX-99.1 16783
8 GRAPHIC g849453g0122014354638.jpg GRAPHIC 5594
9 GRAPHIC g849453g0122014354808.jpg GRAPHIC 844
10 GRAPHIC g849453g0122014354983.jpg GRAPHIC 854
11 GRAPHIC g849453g0122014355175.jpg GRAPHIC 964
  Complete submission text file 0001193125-25-009911.txt   268069

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250121.xsd EX-101.SCH 4471
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250121_def.xml EX-101.DEF 13889
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250121_lab.xml EX-101.LAB 23245
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250121_pre.xml EX-101.PRE 14858
23 EXTRACTED XBRL INSTANCE DOCUMENT d849453d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25543781
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)